On November 4, 2025, Utah Medical Products, Inc. announced the appointment of Kevin Timken as a new board member and an increase in the quarterly cash dividend to $0.31 per share, payable on January 5, 2026. Timken will also serve on the Audit and Compensation Committees and received 10,000 stock options at $58.10 per share.